FierceBiotech4d
Curevo rounds up $110M to challenge GSK’s Shringrix, nabs Moncef Slaoui to lead board
Other new Curevo backers include OrbiMed, Sanofi Ventures and HBM Healthcare Investments. Existing investors RA Capital Management, Janus Henderson Investors and Adjuvant Capital participated in ...
manilatimes4d
Curevo Raises $110 Million to Advance Amezosvatein Shingles Vaccine
Joining Medicxi is an international group of investment funds including OrbiMed, HBM Healthcare Investments, and Sanofi Ventures plus existing investors RA Capital Management, Janus Henderson ...
Mena FN4d
Curevo Raises $110 Million To Advance Amezosvatein Shingles Vaccine
Joining Medicxi is an international group of investment funds including OrbiMed, HBM Healthcare Investments, and Sanofi Ventures plus existing investors RA Capital Management, Janus Henderson ...
FierceBiotech2d
Fierce Biotech Fundraising Tracker '25: Ampersand raises $65M; Arbor adds $74M
A new year means a new Fierce Biotech Fundraising Tracker to record the significant amounts of venture capital being funneled into the industry. We're maintaining the criteria we used for last ...
pharmaphorum1d
Mirador’s massive $400m first round, and other financings
It was led by venture capital firm ARCH Venture Partners, with other prominent biotech investors participating, including OrbiMed, Fairmount, Fidelity Management, and Sanofi Ventures. Mirador ...
Yahoo Finance2d
Traws Pharma, Inc. (TRAW)
After hours: March 19 at 6:42:57 PM EDT Loading Chart for TRAW ...